Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)

SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating the officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) for breaches of fiduciary duty, mismanagement, corporate waste, and violations of the securities laws. Corcept is a pharmaceutical company that develops medications to treat severe metabolic, oncologic, and psychiatric disorders. Corcept's drug Korylm is a cortisol receptor blocker used to control hyperglycemia.

If you would like more information about Corcept Therapeutics Incorporated's misconduct, click here.

Corcept Therapeutics Incorporated (CORT) is Being Investigated for Illicit Sales Practices

On December 8, 2021, Corcept disclosed that "[o]n November 15, 2021, the Company received a records subpoena from the U.S. Attorney's Office for the District of New Jersey (the 'NJ USAO') pursuant to Section 248 of the Health Insurance Portability and Accountability Act of 1996 (HIPPA) seeking information relating to the sale and promotion of Korlym, Corcept's relationships with and payments to health care professionals who can prescribe or recommend Korlym and prior authorizations and reimbursement for Korlym." The Company further disclosed that "[t]he NJ USAO has informed Corcept that it is investigating whether any criminal or civil violations by Corcept occurred in connection with the matters referenced in the subpoena."

On this news, Corcept's stock price fell $3.71 per share, or 16.91%, to close at $18.23 per share on December 8, 2021.

Corcept Therapeutics Incorporated (CORT) shareholders have legal options. If you own shares of Corcept Therapeutics Incorporated, contact us to learn more about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Corcept Therapeutics Incorporated settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:CORT

Release Summary

Corcept Therapeutics Incorporated (CORT) is Being Investigated for Illicit Sales Practices

Release Versions

$Cashtags

Hashtags

#securitiesviolations

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Gartner, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gartner, Inc. (NYSE: IT) common stock between February 4, 2025 and February 2, 2026. Gartner is a global company that provides technology and business insights to its clientele through guidance, tools, conferences, and direct consulting. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003....

Investor Notice: Robbins LLP Informs Investors of the Grocery Outlet Holding Corp. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grocery Outlet Holding Corp. (NASDAQ: GO) securities between August 5, 2025 and March 4, 2026. Grocery Outlet Holding Corp. operates as a retailer of consumables and fresh products sold through independently operated stores in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 35...

Investor Notice: Robbins LLP Informs Investors of the Alight, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Alight, Inc. (NYSE: ALIT) common stock between November 12, 2024 and February 18, 2026. Alight is predominantly an employee benefits solutions company that provides technology-enabled services to employees through the Alight Worklife cloud engagement platform. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a c...

Back to Newsroom